We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$82B
AUM Growth
-$10.6B
Cap. Flow
-$9.58B
Cap. Flow %
-11.68%
Top 10 Hldgs %
17.16%
Holding
2,520
New
6
Increased
1,412
Reduced
634
Closed
36

Top Buys

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$117M
2
WP
Worldpay, Inc.
WP
+$36.3M
3
BDX icon
Becton Dickinson
BDX
+$30.5M
4
BABA icon
Alibaba
BABA
+$29.1M
5
NXPI icon
NXP Semiconductors
NXPI
+$25.3M

Sector Composition

Rank Sector Weight
1 Technology 19.01%
2 Healthcare 14.49%
3 Consumer Discretionary 11.53%
4 Industrials 10.43%
5 Communication Services 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETS icon
1826
PetMed Express
PETS
$43.4M
$1.5M ﹤0.01%
35,900
+2,100
+6% +$97K
EXTN
1827
DELISTED
Exterran Corporation
EXTN
$1.5M ﹤0.01%
56,150
+3,000
+6% +$86.8K
FSP
1828
Franklin Street Properties
FSP
$46.4M
$1.49M ﹤0.01%
177,463
+9,600
+6% +$88.9K
SYNT
1829
DELISTED
Syntel Inc
SYNT
$1.49M ﹤0.01%
58,300
+3,000
+5% +$74.3K
EPZM
1830
DELISTED
Epizyme, Inc
EPZM
$1.49M ﹤0.01%
83,700
EDIT icon
1831
Editas Medicine
EDIT
$432M
$1.49M ﹤0.01%
44,800
HIFR
1832
DELISTED
InfraREIT, Inc.
HIFR
$1.48M ﹤0.01%
76,400
+3,500
+5% +$66.5K
CTS icon
1833
CTS Corp
CTS
$1.79B
$1.48M ﹤0.01%
54,500
+3,300
+6% +$88.8K
EVH icon
1834
Evolent Health
EVH
$527M
$1.48M ﹤0.01%
104,000
+4,800
+5% +$68.7K
COKE icon
1835
Coca-Cola Consolidated
COKE
$12.7B
$1.48M ﹤0.01%
85,650
PRDO icon
1836
Perdoceo Education
PRDO
$1.99B
$1.48M ﹤0.01%
112,500
CNS icon
1837
Cohen & Steers
CNS
$4.4B
$1.48M ﹤0.01%
36,300
+2,100
+6% +$88.2K
GTY
1838
Getty Realty Corp
GTY
$2.05B
$1.48M ﹤0.01%
58,509
+2,400
+4% +$60K
CPF icon
1839
Central Pacific Financial
CPF
$1B
$1.47M ﹤0.01%
51,800
SHAK icon
1840
Shake Shack
SHAK
$2.98B
$1.47M ﹤0.01%
35,400
EGOV
1841
DELISTED
NIC Inc
EGOV
$1.47M ﹤0.01%
110,800
RTEC
1842
DELISTED
Rudolph Technologies Inc
RTEC
$1.47M ﹤0.01%
53,200
BMTC
1843
DELISTED
Bryn Mawr Bank Corp
BMTC
$1.47M ﹤0.01%
33,500
+1,700
+5% +$76.6K
PFBC icon
1844
Preferred Bank
PFBC
$1.28B
$1.47M ﹤0.01%
22,889
+1,500
+7% +$95.7K
TXMD icon
1845
TherapeuticsMD
TXMD
$24.1M
$1.47M ﹤0.01%
6,028
+232
+4% +$65.1K
CRAY
1846
DELISTED
Cray, Inc.
CRAY
$1.46M ﹤0.01%
70,400
+3,300
+5% +$76.5K
AVX
1847
DELISTED
AVX Corporation
AVX
$1.46M ﹤0.01%
87,900
+3,500
+4% +$61.8K
LPSN icon
1848
LivePerson
LPSN
$35.9M
$1.45M ﹤0.01%
5,927
LDL
1849
DELISTED
Lydall, Inc.
LDL
$1.45M ﹤0.01%
30,100
+1,700
+6% +$81.6K
BANC icon
1850
Banc of California
BANC
$3.11B
$1.45M ﹤0.01%
75,100

Similar funds

Swiss National Bank's Q1 2018 Portfolio in Review

As of Q1 2018, Swiss National Bank held 2,520 positions worth $82B, down 11% from $92.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Swiss National Bank withdrew a net $9.58B in Q1 2018, closing 36 positions and reducing 634 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Swiss National Bank opened a new position in Nutrien worth $111M.

  • Swiss National Bank's largest Q1 2018 buy was Nutrien: 2,341,052 shares worth $111M.
  • Swiss National Bank added most to Worldpay, Inc. in Q1 2018, an estimated $36.3M increase.
  • Swiss National Bank's biggest Q1 2018 reduction was Apple, cutting an estimated $443M.
  • Swiss National Bank fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $66.5M.
  • Swiss National Bank's ten largest holdings make up 17% of its $82B portfolio in Q1 2018.
  • Swiss National Bank opened 6 new positions and closed 36 in Q1 2018.
  • Swiss National Bank's portfolio value fell 11% quarter-over-quarter to $82B.

Based on Swiss National Bank's 13F filing for Q1 2018, filed 4 May 2018.